<DOC>
	<DOCNO>NCT01587482</DOCNO>
	<brief_summary>Nowadays , stenting become standard care revascularization superficial femoral artery ( SFA ) atherosclerotic lesion . However , Achilles ' heel technique remain in-stent restenosis ( ISR ) . While local therapy fail demonstrate significant benefit , study treatment SFA ISR lack percutaneous transluminal angioplasty remain current standard care indication . Recent study show successful result drug elute balloon treatment SFA de-novo lesion coronary ISR . FREERIDE , French prospective cohort set evaluate safety efficacy drug elute balloon ( DEB ) treatment SFA atherosclerotic lesion .</brief_summary>
	<brief_title>PacLitaxel Eluting Balloon Application In Sfa In Stent Restenosis</brief_title>
	<detailed_description />
	<mesh_term>Peripheral Arterial Disease</mesh_term>
	<mesh_term>Peripheral Vascular Diseases</mesh_term>
	<mesh_term>Paclitaxel</mesh_term>
	<mesh_term>Albumin-Bound Paclitaxel</mesh_term>
	<criteria>Age â‰¥18 year old Symptomatic patient accord Rutherford Class 1 , 2 , 3 , 4 5 Clinical degradation least 1 Rutherford stage absence heal skin lesion Symptoms relate SFA ISR define PSVR &gt; 2.4 within 3 24 month SFA stenting de novo atherosclerotic lesion . Each patient may either one limb treat study The target ISR lesion fully comprise origin SFA distally femoropopliteal crossover ( cross SFA medial rim femur PA projection ) Adequate SFA inflow outflow either preexist successfully reestablish ( outflow define patency least one infragenicular artery ) The target lesion must extend beyond stent margin Successful cross target lesion , inflow outflow lesion guidewire Patient belongs French health care system Written inform consent No atheromatous disease Asymptomatic lesion Known allergy heparin , aspirin , anticoagulant/antiplatelet therapy , and/or paclitaxel Acute limb ischemia Patient oral anticoagulation therapy Target lesion require / pretreated alternative therapy : DES , laser , atherectomy , cryoplasty , cutting/scoring balloon , etc . Life expectancy &lt; 1 year Patient involve another trial Refusing patient Pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>Superficial femoral artery</keyword>
	<keyword>endovascular</keyword>
	<keyword>Drug elute balloon</keyword>
	<keyword>Paclitaxel</keyword>
</DOC>